FDA Inspection 1100246 — Hospira Australia Pty Ltd.

Hospira Australia Pty Ltd. — FEI 3001174929

The FDA completed an inspection of Hospira Australia Pty Ltd. on July 2, 2019 in Mulgrave. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 2, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mulgrave (Australia)